Browsing by Author "Korica, Stefan (57394407800)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication A retrospective analysis of different treatments of posterior acetabular wall fracture(2023) ;Starčević, Branislav (16064766200) ;Korica, Stefan (57394407800) ;Radojičić, Zoran (6507427734) ;Đorić, Igor (57195032308) ;Kadija, Marko (16063920000)Starčević, Ana (49061458600)Introduction/Objective The objective of the paper is an analysis of clinical outcomes of non-surgical conservative and operative management of patients with posterior acetabular wall fractures. Methods We investigated 88 fractures of the acetabular joint, 31 of which were treated surgically and 57 non-surgically. Only screws or reconstruction plates and screws were used for surgical treatment and traction in patients who underwent nonsurgical treatment. The study period lasted at least three years. The measures used to assess the outcome of operative, surgical and non-operative, conservative approach were Merle d’Aubigné modified score, Harris hip score, and Matta’s radiometric criteria. Results Matta’s evaluation criteria showed an excellent score of 40.4% in conservatively treated patients; 19.4% in patients who underwent surgery; a good score of 49.1% in conservatively treated patients; and 48.4% in patients who underwent surgery. Comparation between two patient groups differently treated, by Merle d’Aubigné tool, showed excellent results for 56.1% conservatively treated patients and 25.8% in those patients who underwent surgery, and good results in 29.8% conservatively treated patients and 38.7% in patients who underwent surgery. Harris hip score (excellent results were showed in 54.4% for non-operative-treated patients) also showed statistical significance, p < 0.005. Conclusion Proper diagnostics and a proper definitive diagnosis can help avoid surgical treatment if the fracture cannot be treated surgically, making the postoperative period more comfortable for the patient. © 2023, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature(2022) ;Fiore, Vito (57189525144) ;Beretta, Rosalba (57437495000) ;De Vito, Andrea (57210853735) ;Barac, Aleksandra (55550748700) ;Maida, Ivana (57207601592) ;Joeseph Kelvin, David David (57437164800) ;Piu, Claudia (56717738900) ;Lai, Vincenzo (57394793100) ;Madeddu, Giordano (55367306300) ;Rubino, Salvatore (55240504800) ;Stevanovic, Goran (15059280200) ;Korica, Stefan (57394407800)Babudieri, Sergio (6603845989)Introduction: SARS-CoV-2 is fundamentally a respiratory pathogen with a wide spectrum of symptoms. The COVID-19 related pancreatitis is less considered than other clinical features. The purpose is to describe two cases of pancreatitis associated with COVID-19. Methodology: Patients' demographics, clinical features, laboratory, and instrumental findings were collected. Results: Two patients admitted to the hospital were diagnosed with COVID-19 and severe acute pancreatitis, according to the Atlanta criteria. Other causes of acute pancreatitis were excluded. Treatment included broad-spectrum antibiotics, proton pump inhibitors, and low molecular weight heparin. Steroids, oxygen, antifungal treatment, and pain killers were administered when appropriate. Both patients were asymptomatic, with normal vital parameters and blood exams, and were discharged in a good condition. Conclusion: It is recommendable to include lipase and amylase on laboratory routine tests in order to evaluate the need for the abdominal CT-scan and specific therapy before hospital admission of the patients with COVID-19 related life-threatening acute pancreatitis. Copyright © 2022 Fiore, Beretta, De Vito, Barac, Maida, Joeseph Kelvin, Piu, Lai, Madeddu, Rubino, Stevanovic, Korica and Babudieri. - Some of the metrics are blocked by yourconsent settings
Publication Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: The case report and the review of literature(2021) ;Adzic-Vukicevic, Tatjana (56888756300) ;Petkovic, Ana (57394209800) ;Menkovic, Nemanja (57113304600) ;Stosic, Maja (57203866961) ;Bracanovic, Milos (57217066096) ;Korica, Stefan (57394407800)Barac, Aleksandra (55550748700)Introduction: We describe the rare case of endobronchial tuberculosis (EBTB) and chronic pulmonary atelectasis with mediastinal distortion. Finding of the concomitant venous anomaly of inferior vena cava revealed the diagnosis of bronchopulmonary sequestration. Case Report: A 22-year-old Caucasian woman presented with a history of chronic cough, initially treated as bronchial asthma for a year. Chest X-ray showed fibrocaseous cavernous tuberculosis on the right lung. Acid Fast Bacilli (AFB) were found in sputum samples. Patient was treated for 6 months with usual antituberculous regiment. Control chest X-ray showed subatelectasis of the upper right lobe. Six months later the first thorax computed tomography (CT) showed complete atelectasis of the right lung. Patient was admitted to the hospital again after 6 years due to the persistent fever and cough. Endoscopic finding and histopathological analysis confirmed EBTB. Thoracic CT scan revealed duplication of inferior vena cava which led to profound vascular analysis and aberrant arterial vascularization of aortic origin that contributed to the diagnosis of bronchopulmonary sequestrations. Antituberculous treatment was initiated (streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide) and lasted for 8 months. After 8 months a follow-up fiberoptic bronchoscopy showed the progression of endoscopic finding with 60-70% tracheal stenosis. Histopathological finding of the mid-trachea showed non-specific granulations. During 7 years of follow-up repeated bronchoscopy and thoracic CT scans were unchanged and patient was well-shaped. Conclusions: The clinician should consider bronchopulmonary sequestration in the cases of recurrent EBTB. Copyright © 2021 Adzic-Vukicevic et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: The case report and the review of literature(2021) ;Adzic-Vukicevic, Tatjana (56888756300) ;Petkovic, Ana (57394209800) ;Menkovic, Nemanja (57113304600) ;Stosic, Maja (57203866961) ;Bracanovic, Milos (57217066096) ;Korica, Stefan (57394407800)Barac, Aleksandra (55550748700)Introduction: We describe the rare case of endobronchial tuberculosis (EBTB) and chronic pulmonary atelectasis with mediastinal distortion. Finding of the concomitant venous anomaly of inferior vena cava revealed the diagnosis of bronchopulmonary sequestration. Case Report: A 22-year-old Caucasian woman presented with a history of chronic cough, initially treated as bronchial asthma for a year. Chest X-ray showed fibrocaseous cavernous tuberculosis on the right lung. Acid Fast Bacilli (AFB) were found in sputum samples. Patient was treated for 6 months with usual antituberculous regiment. Control chest X-ray showed subatelectasis of the upper right lobe. Six months later the first thorax computed tomography (CT) showed complete atelectasis of the right lung. Patient was admitted to the hospital again after 6 years due to the persistent fever and cough. Endoscopic finding and histopathological analysis confirmed EBTB. Thoracic CT scan revealed duplication of inferior vena cava which led to profound vascular analysis and aberrant arterial vascularization of aortic origin that contributed to the diagnosis of bronchopulmonary sequestrations. Antituberculous treatment was initiated (streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide) and lasted for 8 months. After 8 months a follow-up fiberoptic bronchoscopy showed the progression of endoscopic finding with 60-70% tracheal stenosis. Histopathological finding of the mid-trachea showed non-specific granulations. During 7 years of follow-up repeated bronchoscopy and thoracic CT scans were unchanged and patient was well-shaped. Conclusions: The clinician should consider bronchopulmonary sequestration in the cases of recurrent EBTB. Copyright © 2021 Adzic-Vukicevic et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Rifampicin-induced fever during treatment against staphylococcal biofilm in a patient with periprosthetic joint infection(2022) ;Sreckovic, Svetlana (55979299300) ;Ladjevic, Nebojsa (16233432900) ;Jokanovic, Maja (57224685474) ;Vracevic, Dragana (57450491500) ;Milovanovic, Darko (37063548000) ;Simic, Marko (55847076300) ;Korica, Stefan (57394407800)Kadija, Marko (16063920000)Periprosthetic joint infection (PJI) after total knee arthroplasty remains a challenging complication. The treatment options for PJI include different procedures; however, regardless of the strategy, antibiotics are required. The combination of different antibiotics increased the rates of PJI eradication. For almost 3 decades, rifampicin has been used as part of antibiotic therapy for PJI. Drug fever, a febrile response that coincides with the onset of drug administration and disappears after drug discontinuation in the absence of other underlying conditions that could cause fever, is frequently misdiagnosed. We present the case of a 72-year-old man with PJI 6 months after total knee arthroplasty. Two-stage revision surgery was followed by culture-directed antibiotic treatment (ciprofloxacin and rifampicin) against Staphylococcus aureus isolated from the periprosthetic tissue. On the fifth day of antibiotic treatment, the patient became febrile and, in the next 5 days, he had an intermittent fever of up to 40°C, although he showed clinical improvement. The patient was normotensive without a maculopapular rash, urticaria or clotting abnormalities. A drug fever was suspected, and rifampicin was discontinued. A re-challenge test was performed, and the fever recurred. Antibiotic treatment with ciprofloxacin was continued and, after 12 months of follow-up, the patient was doing well. Clinicians should be aware that fever could be a clinical presentation of drug fever. If it occurs during an infection, drug fever could necessitate additional diagnostic procedures for further evaluation, inadequate antibiotic therapy and prolonged hospitalisation. © 2022 British Pharmacological Society. - Some of the metrics are blocked by yourconsent settings
Publication Rifampicin-induced fever during treatment against staphylococcal biofilm in a patient with periprosthetic joint infection(2022) ;Sreckovic, Svetlana (55979299300) ;Ladjevic, Nebojsa (16233432900) ;Jokanovic, Maja (57224685474) ;Vracevic, Dragana (57450491500) ;Milovanovic, Darko (37063548000) ;Simic, Marko (55847076300) ;Korica, Stefan (57394407800)Kadija, Marko (16063920000)Periprosthetic joint infection (PJI) after total knee arthroplasty remains a challenging complication. The treatment options for PJI include different procedures; however, regardless of the strategy, antibiotics are required. The combination of different antibiotics increased the rates of PJI eradication. For almost 3 decades, rifampicin has been used as part of antibiotic therapy for PJI. Drug fever, a febrile response that coincides with the onset of drug administration and disappears after drug discontinuation in the absence of other underlying conditions that could cause fever, is frequently misdiagnosed. We present the case of a 72-year-old man with PJI 6 months after total knee arthroplasty. Two-stage revision surgery was followed by culture-directed antibiotic treatment (ciprofloxacin and rifampicin) against Staphylococcus aureus isolated from the periprosthetic tissue. On the fifth day of antibiotic treatment, the patient became febrile and, in the next 5 days, he had an intermittent fever of up to 40°C, although he showed clinical improvement. The patient was normotensive without a maculopapular rash, urticaria or clotting abnormalities. A drug fever was suspected, and rifampicin was discontinued. A re-challenge test was performed, and the fever recurred. Antibiotic treatment with ciprofloxacin was continued and, after 12 months of follow-up, the patient was doing well. Clinicians should be aware that fever could be a clinical presentation of drug fever. If it occurs during an infection, drug fever could necessitate additional diagnostic procedures for further evaluation, inadequate antibiotic therapy and prolonged hospitalisation. © 2022 British Pharmacological Society.
